| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |